Skip to content

Clinical trials

Phase 2 Eye Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eye Diseases Phase: Phase 2 Country / region: Germany Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20131
20192
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gyroscope Therapeutics Limited2
Alkahest, Inc.1
Amgen1
Novartis Pharmaceuticals1
Oraya Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eye Diseases6
Retinal Diseases4
Retinal Degeneration3
Anetoderma2
Geographic Atrophy2
Macular Degeneration2
Arthritis1
Autoimmune Diseases1
Connective Tissue Diseases1
Dry Eye Syndromes1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.